Cargando…
Publisher Correction: Significant association of cutaneous adverse events with hydroxyurea: results from a prospective non-interventional study in BCR-ABL1-negative myeloproliferative neoplasms (MPN) - on behalf of the German Study Group-MPN
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8632683/ https://www.ncbi.nlm.nih.gov/pubmed/34785798 http://dx.doi.org/10.1038/s41375-021-01366-3 |
_version_ | 1784607797079441408 |
---|---|
author | Stegelmann, Frank Wille, Kai Busen, Hannah Fuchs, Christiane Schauer, Stefanie Sadjadian, Parvis Becker, Tatjana Kolatzki, Vera Döhner, Hartmut Stadler, Rudolf Döhner, Konstanze Griesshammer, Martin |
author_facet | Stegelmann, Frank Wille, Kai Busen, Hannah Fuchs, Christiane Schauer, Stefanie Sadjadian, Parvis Becker, Tatjana Kolatzki, Vera Döhner, Hartmut Stadler, Rudolf Döhner, Konstanze Griesshammer, Martin |
author_sort | Stegelmann, Frank |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8632683 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-86326832021-12-15 Publisher Correction: Significant association of cutaneous adverse events with hydroxyurea: results from a prospective non-interventional study in BCR-ABL1-negative myeloproliferative neoplasms (MPN) - on behalf of the German Study Group-MPN Stegelmann, Frank Wille, Kai Busen, Hannah Fuchs, Christiane Schauer, Stefanie Sadjadian, Parvis Becker, Tatjana Kolatzki, Vera Döhner, Hartmut Stadler, Rudolf Döhner, Konstanze Griesshammer, Martin Leukemia Correction Nature Publishing Group UK 2021-11-16 2021 /pmc/articles/PMC8632683/ /pubmed/34785798 http://dx.doi.org/10.1038/s41375-021-01366-3 Text en © The Author(s), under exclusive licence to Springer Nature Limited 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Correction Stegelmann, Frank Wille, Kai Busen, Hannah Fuchs, Christiane Schauer, Stefanie Sadjadian, Parvis Becker, Tatjana Kolatzki, Vera Döhner, Hartmut Stadler, Rudolf Döhner, Konstanze Griesshammer, Martin Publisher Correction: Significant association of cutaneous adverse events with hydroxyurea: results from a prospective non-interventional study in BCR-ABL1-negative myeloproliferative neoplasms (MPN) - on behalf of the German Study Group-MPN |
title | Publisher Correction: Significant association of cutaneous adverse events with hydroxyurea: results from a prospective non-interventional study in BCR-ABL1-negative myeloproliferative neoplasms (MPN) - on behalf of the German Study Group-MPN |
title_full | Publisher Correction: Significant association of cutaneous adverse events with hydroxyurea: results from a prospective non-interventional study in BCR-ABL1-negative myeloproliferative neoplasms (MPN) - on behalf of the German Study Group-MPN |
title_fullStr | Publisher Correction: Significant association of cutaneous adverse events with hydroxyurea: results from a prospective non-interventional study in BCR-ABL1-negative myeloproliferative neoplasms (MPN) - on behalf of the German Study Group-MPN |
title_full_unstemmed | Publisher Correction: Significant association of cutaneous adverse events with hydroxyurea: results from a prospective non-interventional study in BCR-ABL1-negative myeloproliferative neoplasms (MPN) - on behalf of the German Study Group-MPN |
title_short | Publisher Correction: Significant association of cutaneous adverse events with hydroxyurea: results from a prospective non-interventional study in BCR-ABL1-negative myeloproliferative neoplasms (MPN) - on behalf of the German Study Group-MPN |
title_sort | publisher correction: significant association of cutaneous adverse events with hydroxyurea: results from a prospective non-interventional study in bcr-abl1-negative myeloproliferative neoplasms (mpn) - on behalf of the german study group-mpn |
topic | Correction |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8632683/ https://www.ncbi.nlm.nih.gov/pubmed/34785798 http://dx.doi.org/10.1038/s41375-021-01366-3 |
work_keys_str_mv | AT stegelmannfrank publishercorrectionsignificantassociationofcutaneousadverseeventswithhydroxyurearesultsfromaprospectivenoninterventionalstudyinbcrabl1negativemyeloproliferativeneoplasmsmpnonbehalfofthegermanstudygroupmpn AT willekai publishercorrectionsignificantassociationofcutaneousadverseeventswithhydroxyurearesultsfromaprospectivenoninterventionalstudyinbcrabl1negativemyeloproliferativeneoplasmsmpnonbehalfofthegermanstudygroupmpn AT busenhannah publishercorrectionsignificantassociationofcutaneousadverseeventswithhydroxyurearesultsfromaprospectivenoninterventionalstudyinbcrabl1negativemyeloproliferativeneoplasmsmpnonbehalfofthegermanstudygroupmpn AT fuchschristiane publishercorrectionsignificantassociationofcutaneousadverseeventswithhydroxyurearesultsfromaprospectivenoninterventionalstudyinbcrabl1negativemyeloproliferativeneoplasmsmpnonbehalfofthegermanstudygroupmpn AT schauerstefanie publishercorrectionsignificantassociationofcutaneousadverseeventswithhydroxyurearesultsfromaprospectivenoninterventionalstudyinbcrabl1negativemyeloproliferativeneoplasmsmpnonbehalfofthegermanstudygroupmpn AT sadjadianparvis publishercorrectionsignificantassociationofcutaneousadverseeventswithhydroxyurearesultsfromaprospectivenoninterventionalstudyinbcrabl1negativemyeloproliferativeneoplasmsmpnonbehalfofthegermanstudygroupmpn AT beckertatjana publishercorrectionsignificantassociationofcutaneousadverseeventswithhydroxyurearesultsfromaprospectivenoninterventionalstudyinbcrabl1negativemyeloproliferativeneoplasmsmpnonbehalfofthegermanstudygroupmpn AT kolatzkivera publishercorrectionsignificantassociationofcutaneousadverseeventswithhydroxyurearesultsfromaprospectivenoninterventionalstudyinbcrabl1negativemyeloproliferativeneoplasmsmpnonbehalfofthegermanstudygroupmpn AT dohnerhartmut publishercorrectionsignificantassociationofcutaneousadverseeventswithhydroxyurearesultsfromaprospectivenoninterventionalstudyinbcrabl1negativemyeloproliferativeneoplasmsmpnonbehalfofthegermanstudygroupmpn AT stadlerrudolf publishercorrectionsignificantassociationofcutaneousadverseeventswithhydroxyurearesultsfromaprospectivenoninterventionalstudyinbcrabl1negativemyeloproliferativeneoplasmsmpnonbehalfofthegermanstudygroupmpn AT publishercorrectionsignificantassociationofcutaneousadverseeventswithhydroxyurearesultsfromaprospectivenoninterventionalstudyinbcrabl1negativemyeloproliferativeneoplasmsmpnonbehalfofthegermanstudygroupmpn AT dohnerkonstanze publishercorrectionsignificantassociationofcutaneousadverseeventswithhydroxyurearesultsfromaprospectivenoninterventionalstudyinbcrabl1negativemyeloproliferativeneoplasmsmpnonbehalfofthegermanstudygroupmpn AT griesshammermartin publishercorrectionsignificantassociationofcutaneousadverseeventswithhydroxyurearesultsfromaprospectivenoninterventionalstudyinbcrabl1negativemyeloproliferativeneoplasmsmpnonbehalfofthegermanstudygroupmpn |